The European Myeloma Network
(EMN)
The European Myeloma Network was established in 2003 by integrating 27 research institutions and 14 trial groups with
the intent to support development of novel diagnostics and therapies for multiple myeloma.
Now, EMN is legalised and ready to initiate and support co-operative clinical trials and laboratory research.
The Myeloma Stem Cell Network (MSCNET)
is part of EMN. It is supported by
EU's Sixth Framework Programme.
News
| Agenda Gene expression profiling in Multiple Myeloma 30-31 January 2009 |
Friday 30th January Library Hematology 13th floor
11.30 Welcome and discussion of agenda for the meeting. Pieter Sonneveld
11.45 - 13.30
Which classifiers are currently being developed in multiple myeloma, including classifiers predicting response and toxicity – chair: Herve Avet-Loiseau
13.30 – 14.00 Lunch
14.00 - 15.30
Bioinformatics: which analysis options are currently available for GEP analysis – chair: Antonino Neri
15.30 - 15.45
Coffee/tea
15.45 - 18.30 Computer Instruction Facility 15th floor
Partek/BRB analysis of cluster I of the Hovon-65 data set or a publicly available data set, including normalization, principal component analysis and generating a list of differentially expressed genes. Justine Peeters and Mark van Duin
20.00 Dinner
Saturday 31th January Library Hematology 13th floor
8.30 - 10.00
Standard for collection and storage of biological samples, and methods for sample preparation for GEP – chair: Dirk Hose
10.00 - 11.00
MIAME: international standard for GEP – chair: Vincent Carey (if available)
11.00 - 11.15 Coffee/tea
11.15 - 12.45
Cross-validation of classifiers in multiple myeloma – which parameters are important – chair: Gareth Morgan
12.45 - 13.30
Summary and consensus discussion: All
13.30 -14.30 Closing and lunch
|
|
| 19 Dec 2008 by lindblom |
return to newslist
|
|
